Dalichow assumed his current role in 2025. That year, Bayer partnered with Minapharm to establish Egypt as a regional export hub for Africa and localize the production of seven essential medicines. In 2026, it partnered with Mubadala Bio to expand access to a broader portfolio of healthcare products across the UAE and received the Egyptian Drug Authority’s approval to expand its oral prostate cancer treatment, NUBEQA, for use.